The Eijkman-Oxford Clinical Research Unit (EOCRU) opened in 2008 with the signing of a memorandum of understanding between the Eijkman Institute for Molecular Biology (EIMB) and the University of Oxford, expressing the will to conduct collaborative research on infectious diseases impacting the health of Indonesians and residents of other Southeast Asian nations. EOCRU is embedded within EIMB, effectively functioning as part of the institute, sharing with its host their sophisticated technical resources and laboratories. EOCRU has conducted collaborative research with EIMB and other partners on the epidemiology of severe vivax malaria, clinical trials of primaquine in preventing relapses of vivax malaria, diagnosis of G6PD deficiency, field trials of spatial repellents in diminishing human contact with malaria-bearing anopheline mosquitoes, viral and parasitic infections of non-human primates relevant to human health, a clinical trial of oseltamivir treatment of avian and human influenza in hospitalized patients, and clinical descriptions of patients hospitalized with avian influenza.
EOCRU also serves as the Asia-Pacific base for the Malaria Atlas Project at University of Oxford, and works closely with colleagues in the Sub-directorate for Malara Control in the Ministry of Health's Center for Disease Control in producing research products that support their operations. In addition to EIMB, EOCRU partners with the Faculty of Medicine University of Indonesa, School of Public Health Hasanuddin University, Health Services of the Armed Forces of Indonesia, Princeton University, and the ALERTAsia Foundation. EOCRU has enjoyed the generous support of Oxford University, the Wellcome Trust, the U.S. National Institutes of Health, the Medicine for Malaria Venture, PATH, Li KaShing Foundation and the Bill & Melinda Gates Foundations. EOCRU seeks the development of collaborative research ventures on infectious diseases through partnership with its Indonesian hosts and mutually interested research groups from abroad, especially those bringing relevant research experiences and capacities to our Indonesian friends.
